Last updated on December 2018

Open-Label Extension and Safety Study of Talazoparib

Brief description of study

This is a single-arm, open-label, extended treatment, safety study in patients treated with talazoparib in qualifying studies.

Clinical Study Identifier: NCT02921919

Contact Investigators or Research Sites near you

Start Over

Pfizer Pfizer Call Center

UCLA Hematology/Oncology - Santa Clarita
Valencia, CA United States
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.